Please login to the form below

Not currently logged in
Email:
Password:

payer

This page shows the latest payer news and features for those working in and with pharma, biotech and healthcare.

Segmentation, evolved

Segmentation, evolved

They are now segmenting prescribing contexts created by the convergence of payer, prescriber and patient needs. ... Sanofi has done so via contextual segmentation, then targeting a specific payer/patient/prescriber context, then developing a discount

Latest news

More from news
Approximately 7 fully matching, plus 524 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    And we need healthcare payers to recognise the true value of innovative antibiotics to the healthcare system.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    With the emergence of an increasing number of therapies in rare disease, biopharmaceutical companies have a real opportunity to work in true partnership with HCPs, payers and healthcare systems to accelerate ... In terms of generating impactful change,

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    With the emergence of an increasing number of therapies in rare disease, biopharmaceutical companies have a real opportunity to work in true partnership with HCPs, payers and healthcare systems to accelerate ... In terms of generating impactful change,

  • Six degrees of participation Six degrees of participation

    A global evolution of technologies, expectations and behaviours is forcing providers, physicians and payers to rethink healthcare models and redefine patient communications. ... Likewise, payers know that patient empowerment is vital if they’re to

  • Health on instalment Health on instalment

    For example, Luxturna maker Spark Therapeutics approached a commercial payer with a pay-for-performance option. ... And providers and payers lack the kind of financial clout needed to float such immense lines of credit.

More from intelligence
Approximately 5 fully matching, plus 178 partially matching documents found.

Latest appointments

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    In this role, Hurrell oversaw the team’s market access communications offering, supporting clients in the development of value communications materials with the payer as the ultimate end audience, including core ... value dossiers, payer-focused

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Acumen appoints new strategy director Acumen appoints new strategy director

    policy makers, patient representatives, media, regulators and payers.

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... She said: “I am delighted to be part of an organisation with such an active focus

  • Dr Gopalan Narayanan joins VCLS Dr Gopalan Narayanan joins VCLS

    interactions with regulators and payers.

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 12 fully matching, plus 143 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics